News

Pharmaceutical Executive
pharmexec.com > view > eli-lilly-8-billion-strategic-collaboration-innovent-biologics-acquires-orna-therapeutics

Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics | PharmExec

Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics | PharmExec1+ hour, 35+ min ago   (316+ words) Eli Lilly's deals with Orna Therapeutics and Innovent Biologics helps structure Lilly's global development and commercialization in ways that balance regional expertise with worldwide scale. Eli Lilly reinforced its push into next-generation immunology and oncology innovation through two major transactions:…...

Pharmaceutical Executive
pharmexec.com > view > next-generation-trial-designs-supplementing-real-world-data

The Next Generation of Trial Designs: Supplementing Trials with Real-World Data | PharmExec

The Next Generation of Trial Designs: Supplementing Trials with Real-World Data | PharmExec4+ hour, 52+ min ago   (640+ words) As innovative clinical trial designs gain traction, Billy Amzal, Head of Strategic Consulting at Phastar, discusses how to use real-world data effectively, shares practical examples and looks to the future of patient simulators and synthetic patients. However, drug developers must…...

Pharmaceutical Executive
pharmexec.com > view > daily-launch-trumprx

Pharmaceutical Executive Daily: The Launch of TrumpRx | PharmExec

Pharmaceutical Executive Daily: The Launch of TrumpRx | PharmExec2+ day, 19+ hour ago   (156+ words) Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, TrumpRx officially launches, the FDA moves against mass marketing of illegal copycat drugs, and AI emerges…...

Pharmaceutical Executive
pharmexec.com > view > everything-know-trumprx-2026

Everything to Know About TrumpRx in 2026 | PharmExec

Everything to Know About TrumpRx in 2026 | PharmExec2+ day, 19+ hour ago   (375+ words) TrumpRx is meant to reduce drug costs, but Americans are wondering how it works and what impact it will have. No, TrumpRx does not sell medications. Instead, it provides users with coupons that can be redeemed at pharmacies and/or…...

Pharmaceutical Executive
pharmexec.com > view > trumprx-is-live-complicated

TrumpRx Is Live and Complicated | PharmExec

TrumpRx Is Live and Complicated | PharmExec3+ day, 21+ hour ago   (430+ words) The site offers users coupons for a limited number of medications that can be redeemed at pharmacies and/or manufacturer DTC sites. After months of speculation, TrumpRx is live and offering Americans a variety of important medications at most-favored-nation prices....

pharmexec.com
pharmexec.com > view > daily-susan-g-komen-releases-breast-cancer-outlook-2026

Pharmaceutical Executive Daily: Susan G. Komen Releases Breast Cancer Outlook for 2026 | PharmExec

Pharmaceutical Executive Daily: Susan G. Komen Releases Breast Cancer Outlook for 2026 | PharmExec4+ day, 21+ hour ago   (218+ words) Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, Susan G. Komen releases its 2026 breast cancer progress outlook, industry leaders explore how pharma can tap into…...

Pharmaceutical Executive
pharmexec.com > view > from-or-office-how-workflow-change-ai-reshaping-medtech-adoption

From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption | PharmExec

From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption | PharmExec6+ day, 4+ hour ago   (328+ words) Dave Carey, CEO, Preceptis Medical and Michael Manavukas, CEO, co-founder, AcuityMD note the importance of shifting ear tube procedures into the office, reducing anesthesia risk, and how AI-driven data and adaptive commercial strategies are becoming critical to scaling new medtech…...

Pharmaceutical Executive
pharmexec.com > view > fda-precheck-domestic-manufacturing-pilot-program

FDA Announces New Domestic-Manufacturing-Focused Pilot Program | PharmExec

FDA Announces New Domestic-Manufacturing-Focused Pilot Program | PharmExec6+ day, 7+ hour ago   (360+ words) FDA PreCheck will provide benefits to manufacturing sites that fit criteria focused on benefiting the United States. One of President Trump's stated goals across all industry has been a desire to reduce the United State's dependence on imported goods. While…...

Pharmaceutical Executive
pharmexec.com > view > experience-debuting-trialynx-jp-morgan-healthcare-2026

What Was Your Experience Debuting Trialynx at JP Morgan Healthcare 2026? | PharmExec

What Was Your Experience Debuting Trialynx at JP Morgan Healthcare 2026? | PharmExec6+ day, 11+ hour ago   (424+ words) Angela Schwab, CEO at Trialynx, continues her conversation with Pharmaceutical Executive, this time detailing her experience with debuting her company at the conference. Pharmaceutical Executive: What AI trends did you see at the 2026 JP Morgan Healthcare Conference?Angela Schwab: Good…...

pharmexec.com
pharmexec.com > view > burnout-shortages-blood-supply-risk

Burnout and Shortages Put the Blood Supply at Risk | PharmExec

Burnout and Shortages Put the Blood Supply at Risk | PharmExec6+ day, 23+ hour ago   (764+ words) Persistent blood shortages compounded by widespread laboratory staffing burnout and vacancies are straining transfusion medicine, making investment in lab workforces critical to safeguarding patient access to lifesaving blood supplies. Blood transfusions offer a critical lifeline for patients with conditions such…...